[Investor Updates]PharmAbcine, non-confidential slide deck Q4 2021
3 Dec 2021
[Investor Updates]PharmAbcine, non-confidential slide deck Q4 2021
2F, Research Building 2, 70,
Yuseong-daero 1689 beon-gil,
Yuseong-gu, Daejeon, 34047, Republic of Korea
HQ +82-42-863-2017
R&D Center +82-42-861-2017
Investor Relations +70-4294-6097
FAX +82-42-863-2080
COPYRIGHT BY PharmAbcine Inc.
ALL RIGHTS RESERVE
Notice of Changes:
1. The introduction slides on company overview, core technologies, and main pipelines have been modified
2. The company’s long-term growth strategy slide has been added
3. Olinvacimab’s phase 2 mTNBC (metastatic Triple-Negative Breast Cancer) clinical design slide has been added
4. A market potential slide of PMC-403 in ophthalmology has been added
5. A slide on the PMC-309’s strengths in the current immuno-oncology market has been added
Please check the attached file for details.
Thank you for your continued support.